Call Us Today:
949.200.1600

Sentinal Lymph Node Biopsy

Home > Treatment > Surgical Treatment > Sentinel Lymph Node Biopsy

Skin-Cancer-Specialists-Skin-Cancer-Treatment-Sentinel-Lumph-Node-Biopsy-Skin-Cancer-and-Reconstructive-Surgery-Center-Orange-County

About Sentinel Lymph Node Biopsy

Sentinel Lymph Node Biopsy (SLNB) is a surgical procedure used to determine the extent of involvement or stage of certain types of cancers such as melanoma, breast cancer, squamous cell carcinoma, and basosquamous cell carcinoma. The test determines if cancerous cells have metastasized from the original, primary tumor site into the lymph nodes. Thus, SLNB determines the prognosis and guides the treatment.

 

The lymphatic system carries lymphatic fluid to the central chest, and is interrupted by multiple filters along the way - the lymph nodes. The lymphatic system provides a pathway for cancer cells to travel and spread. The first node to receive lymphatic drainage from a tumor is called the sentinel lymph node. Cancer cells may appear in the sentinel node before spreading to other lymph nodes.

 

SLNB is done prior to removal of the main tumor. It is a two step process which involves first identifying the sentinel lymph node followed by its removal and microscopic evaluation. The process begins at a Nuclear Medicine department of a radiology facility. The radiologist injects a harmless radioactive substance near the tumor. After 15 – 60 minutes, the area is scanned with radiation detectors to show where the substance has traveled within the lymphatic system. The images of this are then taken by the patient to their scheduled biopsy at a surgical facility.

 

In the operating room, the surgeon will use the Nuclear Medicine images as well as a special radiation-detecting probe (Gamma probe) to identify the greatest concentration of the radioactive tracer. Like cancer cells, the radioactive tracer will get temporarily trapped in a lymph node--a filter of the lymphatic system. The first lymph node to show the radioactive tracer is the sentinel lymph node. Frequently, the surgeon also injects a dye called methylene blue into the tumor prior to surgery. 15-30 minutes later, when the lymph node is being identified with the gamma probe, the dye can be seen staining the sentinel lymph node. This helps confirm that this is indeed the first lymphatic filter for the cancer.

 

Once the the surgeon identifies the lymph node, it is removed. The lymph node is sent to a pathologist for specialized testing to identify cancer cells. Identification of cancer cells within the sentinel lymph node results in more aggressive treatment such as radiation therapy, extensive lymph node removal, or even chemotherapy.

Related Articles

A Modern Test for Melanoma
DecisionDx Melanoma is enhancing medical decision making in invasive melanoma stages I, II, and III.. Management of cutaneous melanoma involves strategic risk assessment and oncologic work-up. This typically includes staging, wide local excision, and possible sentinel lymph node biopsy or biologic therapy.  Traditionally, surgeons perform a sentinel lymph node biopsy (SLNB) if the possibility of…
Read More
Multiple Cutaneous Carcinomas in Organ Transplant Recipients
HISTORY  A 73-year-old kidney transplant recipient presented with multiple carcinomas including SCC, SCC in situ, and BCC of the face and scalp. DISCUSSION Organ transplant recipients can suffer from multiple cutaneous carcinomas. Some lesions can have a high risk of metastases, but most occur in multitudes in areas of extensive sun exposure. At SCARS Center,…
Read More
Sentinel Lymph Node Biopsy for Cutaneous SCC
HISTORY A 58-year-old kidney transplant recipient presented with a 6-month history of squamous cell carcinoma of the left scalp. This large lesion was adjacent to the scar of a previous carcinoma excision in 2014. Patient is on sirolimus for his kidney transplant performed in 1984. He has had multiple BCCs and SCCs of scalp, back,…
Read More
Skin-Cancer-And-Reconstructive-Surgery-Foundation-melanoma-with-recurrent-MIS1
Melanoma within recurrent MIS
HISTORY   73-year-old woman presents with 1-year history of recurrent pigmented lesion of the right nasal ala  found to be invasive melanoma with 0.5 mm invasion. Patient’s history began 9 years ago in 2009 with excision of a melanoma in situ and skin graft closure. In 2012, pigmentation adjacent to the graft site was found…
Read More
Skin-Cancer-And-Reconstructive-Surgery-Foundation-Scalp-SCC-Metastasis-to-neck-CT-PET-scan
Scalp SCC Metastasis to Neck
HISTORY   64-year-old man presents in 11/2017 with tender, right postauricular swelling. Fine needle aspiration biopsy showed squamous cell carcinoma. Extensive squamous cell carcinoma of scalp was treated with 4 levels of Mohs earlier that year in 01/2017. Additional smaller squamous cell carcinoma of the same area of the scalp was treated with Mohs in…
Read More
Recurrent-Melanoma-SCARS-Center-Case-2-Skin-Cancer-And-Reconstructive-Surgery-Center-Orange-County4
RECURRENT MELANOMA
  HISTORY 70-year-old woman presents with metastatic melanoma in the right parotid gland region of 1 year duration. Diagnosis was made with a core needle biopsy on 09-08-17. Patient also has small palpable right cervical lymph nodes with SUV 1.6 and 2.0. Patient history of melanoma began in 2001 as a pink macule of the…
Read More

STAY UP TO DATE

Receive research updates, inspiring stories, healthy living tips and more.

Something went wrong. Please check your entries and try again.

FOLLOW US

ELEVATING THE STANDARDS OF SKIN CANCER MANAGEMENT.

© 2018 SCARS Management Services. All rights reserved.